Response to Secukinumab Shows Variations Across Psoriatic Arthritis Clusters
Researchers compared the effect of secukinumab on the quality of life of patients with very early and established psoriatic arthritis.
Researchers compared the effect of secukinumab on the quality of life of patients with very early and established psoriatic arthritis.
Survival and discontinuation rates of infliximab when treating psoriasis in real world conditions were analyzed.
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Researchers evaluated the performance of carotid ultrasound in distinguishing between patients with psoriatic arthritis with and without coronary artery disease.
Researchers evaluated the changes in serum levels of different regulators and markers of bone formation in patients with early axial spondyloarthritis.
Researchers evaluated the predictive value of the Ankylosing Spondylitis Work Instability Scale on work impact in axial spondyloarthritis.
A case report of a patient with 20-year, unstable psoriasis who presented with new erthroderma and subsequent treatment with systemic corticosteroids and methotrexate.
Researchers assessed the interchangeability of 2 measures of minimal disease activity in psoriatic arthritis.
Researchers determined the efficacy and safety of ixekizumab vs adalimumab in bionaive patients with psoriatic arthritis.
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.